Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Alberta

$17,500.00

Whole Genome Analysis of Childhood Cancer Survivor Cohorts for Investigation of Late Term Sequelae

FY 2015-16

Summary
Although over 80% of childhood cancer patients become five-year survivors, 73% of these survivors develop a chronic health condition within 30 years from cancer diagnosis and 42% consequently develop a severe or life-threatening condition1, 2.To improve quality of life after childhood cancer, it is critical to identify high-risk survivors for specific types of sequelae and provide targeted risk-based interventions and follow-up care. This risk prediction is currently not of high enough precision, however, for it to have sufficient clinical utility. My proposed research is to improve the precision of this risk prediction by incorporating genetic profiles of survivors. Identification of genomic variants that modify survivors' risk to these therapy-induced outcomes (e.g., genes that control sensitivity to radiation) would allow for personalized cancer treatments and follow-up care with the ultimate goal of reducing the incidence of severe late sequelae. Specifically, I will analyze Childhood Cancer Survivor Study (CCSS) and St. Jude Life Cohort Study (SJL) datasets, which have exceptional genetic as well as clinical characterizations of long-term childhood cancer survivors, with a combined sample size exceeding 35,000. Utilizing my biology research background, the collaborative Yasui lab, and the exceptional data provided by the CCSS and SJL, I will integrate epidemiological and genomic analyses to address how genetic profiles predispose childhood cancer survivors to treatment- and cancer-induced late effects.References:1. Ries et al. Cancer Statistics Review, 1975–2005. Bethesda, MD: National Cancer Institute; 2008.2. Oeffinger et al. N Engl J Med. 2006; 355:1572-1582.
Program
Master's Award: Canada Graduate Scholarships
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
349883
Name
Baedke Jessica L
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Whole Genome Analysis of Childhood Cancer Survivor Cohorts for Investigation of Late Term Sequelae
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Childhood Cancer; Cohort Studies; Gene Treatment Interaction; Genetic Epidemiology; Late Effects Of Cancer Therapies; Snp Arrays; Whole-Exome Sequencing; Whole-Genome Sequencing
Abstract
Although over 80% of childhood cancer patients become five-year survivors, 73% of these survivors develop a chronic health condition within 30 years from cancer diagnosis and 42% consequently develop a severe or life-threatening condition1, 2.To improve quality of life after childhood cancer, it is critical to identify high-risk survivors for specific types of sequelae and provide targeted risk-based interventions and follow-up care. This risk prediction is currently not of high enough precision, however, for it to have sufficient clinical utility. My proposed research is to improve the precision of this risk prediction by incorporating genetic profiles of survivors. Identification of genomic variants that modify survivors' risk to these therapy-induced outcomes (e.g., genes that control sensitivity to radiation) would allow for personalized cancer treatments and follow-up care with the ultimate goal of reducing the incidence of severe late sequelae. Specifically, I will analyze Childhood Cancer Survivor Study (CCSS) and St. Jude Life Cohort Study (SJL) datasets, which have exceptional genetic as well as clinical characterizations of long-term childhood cancer survivors, with a combined sample size exceeding 35,000. Utilizing my biology research background, the collaborative Yasui lab, and the exceptional data provided by the CCSS and SJL, I will integrate epidemiological and genomic analyses to address how genetic profiles predispose childhood cancer survivors to treatment- and cancer-induced late effects.References:1. Ries et al. Cancer Statistics Review, 1975–2005. Bethesda, MD: National Cancer Institute; 2008.2. Oeffinger et al. N Engl J Med. 2006; 355:1572-1582.
Competitiondate
201512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Baedke, Jessica L
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~